| November 5, 2009 8:00 am – 6:00 pm |
Boston University Trustee Ballroom 1 Silber Way, 9th Floor Boston, MA, USA 02115 |
 |
This year marks the debut of the NCI SBIR Investor Forum, an exclusive event designed to connect the strongest and most promising NCI SBIR companies with biotechnology investors and strategic partners. This is a rare opportunity for you to get a first look at some of the best early-stage oncology companies currently funded by the NCI and will offer opportunities to foster new and unique collaborations.
Join us on November 5, 2009 as we showcase the top 10-15 SBIR companies focused on innovative research in cancer-related technologies, selected by strength of research, impact on cancer, product development and market potential. These breakthrough discoveries are primed for commercialization and will be the next generation of cancer therapeutics, imaging products, diagnostics, and other important technologies in the fight against cancer. All companies presenting will be pre-screened by an independent panel of experts from venture capital firms, bio-pharmaceutical, and medical device companies. Company representatives will be available for formal and informal networking to discuss their programs and partnership opportunities.
Opportunities for Investors and Strategic Partners:
- Learn about and meet with a select group of small businesses that are developing innovative and groundbreaking diagnostic, therapeutic, bioinformatics, imaging products, and other cancer-related technologies
- Attend private breakout sessions with top SBIR-funded companies
- Meet with NCI SBIR Development Center leadership to learn about the NCI SBIR Bridge Award, a unique $3 million funding opportunity to accelerate promising cancer-related technologies to commercialization
- Engage with NCI SBIR Development Center staff to discuss upcoming funding and opportunities to leverage investments to catalyze the commercialization of cancer prevention, detection, and treatment technologies and therapeutics
Event Highlights:
- Panel session featuring successful partnerships between recent SBIR Phase II Bridge Award Winners and their venture capital investors
- Networking reception with featured companies, investors and industry executives from the oncology community
- Luncheon and Keynote Presentation
Seating is limited; therefore, registration is required. Register today to reserve a space.
Note to presenters: Presenters have been preregistered. If your company would like to send additional representatives, please register here.
This forum is sponsored by The National Cancer Institute's SBIR Development Center in partnership with Boston University's Office of Technology Development, and other collaborators.